Ubiquitin-proteasome system and increased sensitivity of B-CLL lymphocytes to apoptotic death activation

Leukemia and Lymphoma

Volumn 38, Issue 5-6, 2000, Pages 499-504

  Masdehors, Peggy ^a   Merle Béral, Hélène ^b   Magdelénat, Henri ^a   Delic, Jozo ^a  

^a INSTITUT CURIE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Apoptosis; B cell; Lactacystin; Ubiquitin proteasome

Indexed keywords

LACTACYSTIN; PROTEASOME; UBIQUITIN;

APOPTOSIS; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; REMISSION; REVIEW;

EID: 0343091329     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009059268     Document Type: Review

References (49)

1. Dive, C., and Hickman, J. A. (1991) Drug-target interactions: only the first step in the commitment to a programmed cell death. Br. J. Cancer, 64, 192-196.
2. Sach, L., and Lotem, J. (1993) Control of programmed cell death in normal and leukemic cells: new implications for therapy. Blood, 82, 15-21.
3. Martin, S. J., and Green, D. R. (1994) Apoptosis as a goal of cancer therapy. Cur. Opinion Oncol., 6, 616-621.
4. Dubray, B., Breton, C., Delic, J., Klijanijenko, J., Maciorowski, Z., Vielh, P., Fourquet, A., Dumont, J., Magdelénat, H., and Cosset, J-M. (1998) In vitro radiation-induced apoptosis and early response to low-dose radiotherapy in non-Hodgkin's lymphomas. Radiother. Oncol., 46, 185-1991.
5. Reed, J. C. (1998) Molecular biology of chronic lymphocytic leukemia. Seminars in Oncology, 25, 11-18.
6. Tanaka, K., Tamura, T., Yoshimura, T., and Ichihara, A. (1992) Proteasomes: protein and gene structures. New Biologist, 4, 173-187.
7. Ciechanover, A. (1998) The ubiquitin-proteasome pathway: on death and cell life. EMBO J., 17, 7151-7160.
8. Hershko, A., and Ciechanover, A. (1998) The ubiquitin system. Ann. Rev. Biochem., 67, 425-479.
9. Sadoul, R., Fernandez, P-A., Quiquerez, A-L. Martinou, I., Maki, M., Schrôter, M., Becherer, J. D., Irmler, M., Tschopp, J., and Martinou, J-C. (1996). Involvement of the proteasome in the programmed cell death of NGF-deprived symphatetic neurons. EMBO J., 15, 3845-3852.
10. Drexler, H. C. A. (1997) Activation of the cell death program by inhibition of proteasome function. Proc. Natl. Acad. Sci. U.S.A., 94, 855-860.
11. Lopes, U. G., Erhardt, P., Yao, R., and Cooper, G. M. (1997) p53-dependent induction of apoptosis by proteasome inhibitors. J. Biol. Chem., 272, 12893-12896.
12. Delic, J., Masdehors, P., Ömura, S., Cosset, J-M., Dumont, J., Binet, J-L., and Magdelénat, H. (1998) The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-α-initiated apoptosis. Br. J. Cancer, 77, 1103-1107.
13. Delic, J., Coppey-Moisan, M., and Magdelénat, H. (1993a) γ-ray-induced transcription and apoptosis-associated loss of 28S rRNA in interphase human lymphocytes. Int. J. Radiat. Biol., 64, 39-46.
14. Delic, J. Morange, M., and Magdelénat, H. (1993b) Ubiquitin pathway involvement human lymphocyte γ-irradiation-induced apoptosis. Mol. Cell. Biol., 13, 4875-4883.
15. Delic, J., Magdelénat, H., Barharoux, C., Chaillet, M-P., Duhray, B., Gluckman, E., Fourquet, A., Girinsky, T., and Cosset, J-M. (1995) In vivo induction of apoptosis in human lymphocytes by therapeutic fractionated total body irradiation. Br. J. Radiology, 68, 997-1003.
16. Schwartz, L. M., Myer, A., Kosz, L., Engelstein, M., and Maier, C. (1990) Activation of polyubiquitin gene expression durring developmentally programmed cell death. Neuron, 5, 411-419.
17. Wright, D. A., Futvher, B., Ghosh, P., and Geha, R. S. (1996) Association of human Fas (CD95) with a ubiquitin-conjugating enzyme (UBC-FAP). J. Biol. Chem., 271, 31037-31043.
18. Becker, K., Schneider, P., Hofinann, K., Mattmann, C, and Tschopp, J. (1997) Interaction of Fas (Apo-1/CD95) with proteins implicated in the ubiquitination pathway. FEBS Lett., 412, 102-106.
19. Monney, L., Otter, I., Olivier, R., Ozer, H. L., Haas, A. L., Ömura, S., and Borner, C. (1998) Defect in the ubiquitin pathway induces caspase-independent apoptosis blocked by bcl-2. J. Biol. Chem., 273, 6121-6131.
20. Salvesen, G. S., and Dixit, V. M. (1997) Caspases: intracellular signaling by proteolysis. Cell, 91, 443-446.
21. Cryns, V., and Yuan, J. (1998) Proteases to die for. Genes Devel., 12, 1551-1570.
22. Hirsch, T., Dallaporta, B., Zamzami, N., Susin, S.A., Ravagnan, L., Marzo, I., Brenner, C., and Kroemer, G. (1998) Proteasome activation occurs at an early, premitochondrial step of thymocyte apoptosis. J. Immunol., 161, 35-40.
23. Spataro, V., Norbury, C., and Haris, A. (1998) The ubiquitin-proteasome pathway in cancer. Br. J. Cancer, 77, 448-454.
24. Oikawa, T., Sasaki, T., Nakamura, M., Shimamura, M., Tanahashi, N., Ömura, S., and Tanaka, K. (1998) The proteasome is involved in angiogenesis. Biochem. Biophys. Res. Commun., 246, 243-248.
25. Mariano, M. T., Moretti, L. Donelli, A., Grantini, M., Montagnani, G., Di Prisco, A. U., Torelli, G., Torelli, U., and Narni, F. (1992) bcl-2 gene expression in hematopoietic cell differentiation. Blood, 80, 768-775.
26. Kitada, S. Andersen, J., Akar, S., Zapata, J. M., Takayama, S., Krayewski, S., Wang H. G., Zhang, X., Bullrich, F., Croce, C. M., Rai, K., Hines, J., and Reed, J. C. (1998) Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood, 91, 3376-3389.
27. Muller, C., and Salles, B. (1997) Regulation of DNA-dependent protein kinase activity in leukemic cells. Oncogene, 15, 2343-2348.
28. Christodoulopoulos, G., Muller, C., Salles, B., Kazmi, R., and Panasci, L. (1998) Potentiation of chlorambucil cytotoxicity in B-cell chronic lymphocytic leukemia by inhibition of DNA-dependent protein kinase activity using wortmanin. Cancer Res., 58, 1789-1792.
29. Masdehors, P., Ömura, S., Merle-Béral, H., Mentz, F., Cosset, J-M., Dumont, J., Magdelénat, H., and Delic, J. (1999) Increased sensitivity of CLL-derived lymphocytes to apoptotic death activation by the proteasome-specific inhibitor lactacystin. Br. J. Haematology, 105, 752-757.
30. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., and Verma, I. M. (1996) Suppression of TNF-a-induced apoptosis by NF-KB. Science, 274, 787-789.
31. Liu, Z-G., Hailing, H., Goeddel, D. V., Karin, M. (1996) Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-KB activation prevents cell death. Cell, 87, 565-576.
32. Masdehors, P., Merle-Béral, H., Maloum, K., Magdelénat, H., and Delic, J. (1998) Implication of the ubiquitin-proteasome system in apoptosis of CLL cells. Blood, 92, Sup 1 Abstract 2639.
33. Ömura, S., Fujimoto, T., Otoguro, K., Matsuzaki, K., Moriguchi, R., Tanaka, H., and Sasaki, I. (1991) Lactacystin, a novel microbial metabolite, induces neuritogenesis of neuroblastoma cells. J. Antibiotics, 44, 113-116.
34. Fenteany, G., Standaert, R. E., Lane, W. S., Choi, S., Correy, E. J., and Schreiber, S. L. (1995) Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science, 268, 726-731.
35. Chandra, J., Niemer, I., Gilbreath, J., Kliche, K. O., Andreeff, M., Friereich, E. J., Keating, M., and McConkey, D. J. (1998) Proteasome inhibitors induce apoptosis in glucocorticoid-resistant chronic lymphocytic leukemic lymphocytes. Blood, 92, 4220-4229.
36. Starostik, P., Manshouri, T., O'Brien, S., Freireich, E., Kantarijan, H., Haidar, M., Lerner, S., Keating, M., and Albitar, M. (1998) Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia. Cancer Res., 58, 4552-4557.
37. Bulrich, F., Rasio, D., Kitada, S., Starostik, P., Kipps, T., Keating, M., Albitar, M., Reed, J. C., and Croce, C. M. (1999) ATM mutations i B-cell chronic lymphocytic leukemia. Cancer Res., 59, 24-27.
38. Stankovic, T., Weber, P., Stewart, G., Bedenham, T., Murray, J., Byrd, P. J., Moss, P. A. H., and Taylor, A. M. R. (1999) Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet, 353, 26-29.
39. Corey, E. J. and Reichard, G. A. (1992) Total synthesis of lactacystin. J. Am. Chem. Soc., 114, 10677-10678.
40. Corey, E. J., Reichard, G. A., and Kania, R. (1993) Studies on the total synthesis of lactacystin. An improved aldol coupling reaction and a β-lactone intermediate in thiol ester formation. Tetrahedron Lett., 34, 6977-6980.
41. Dick, L. R., Cruikshank, A. A., Grenier, L., Melandri, F. D., Nunes, S. L., and Stein, R. L. (1996) Mechanistic studies on the inactivation of the proteasome by lactacystin: a central role for the clasto-lactacystin beta-lactone. J. Biol. Chem., 271, 7273-7276.
42. Dick, L. R., Cruikshank, A. A., Destree, A. T., Grenier, L., McCormack, T. A., Melandri, F. D., Nunes, S. L., Palombella, V. J., Parent, L. A., Plamondon, L., and Stein, R.L. (1997) Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells. J. Biol. Chem., 272, 182-188.
43. Rock, K.L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., and Goldberg, A. L. (1994) Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC clas I molecules. Cell, 78, 761-7712.
44. Squier, M. K. T., and Cohen, J. J. (1997) Calpain, an upstream regulator of thymocyte apoptosis. J. Immunol., 158, 3690-3697.
45. Waterhouse, N. J., Finucane, D. M., Green, D. R., Elce, J. S., Kumar, S., Alnemri, E. S., Litwack, G., Khanna, KK., Lavin, M. F., and Watters, D. J. (1998) Calpain activation is upstream of caspases in radiation-induced apoptosis. Cell Death Differ., 5, 1051-1061.
46. Mellgren, R. L. (1997) Specificities of cell permeant peptidyl inhibitors for the proteinase activities of μ-calpain and the 20S proteasome. J. Biol. Chem., 272, 29899-29903.
47. Lin, K-I., Baraban, J. M., and Ratan, R. R. (1998) Inhibition versus induction of apoptosis by proteasome inhibitors depends on concentration. Cell Death Differ., 5, 577-583.
48. Masdehors, P., Merle-Béral, H., Maloum, K., Ömura, S., Magdelénat, H., and Delic, J. (2000) Deregulation of the ubiquitin system and p53 proteolysis modify the apoptotic response in B-CLL lymphocytes. (Blood, in press).
49. Mimnaugh, E. G., Chen, H. Y., Davie, J. R., Celis, E., and Neckers, L., (1997) Rapid deubiquitination of nucleosomal histones in human tumor cells caused by proteasome inhibitors and stress response inducers: effects on replication, transcription, translation, and the cellular stress response. Biochemistry, 36, 14418-29.